Convulsive Status Epilepticus in a Child With Controlled Epilepsy and Concurrent COVID-19 Infection: A Case Report
Abdulhafeez M Khair1, Sumair Husain1, Gurcharanjeet Kaur1,2
1Division of Neurology, Nemours/Alfred I. DuPont Hospital for Children, Wilmington, DE, USA.
Clinical Medicine Insights. Case Reports
|August 30, 2021
Summary
The COVID-19 pandemic offers insights into viral infections affecting the nervous system. This study details a child with seizures and COVID-19, highlighting SARS-CoV-2
Area of Science:
- Neurology
- Infectious Diseases
- Pediatrics
Background:
- The COVID-19 pandemic has revealed complex interactions between viral infections and the human nervous system.
- Limited research exists on the neuroinvasive and neurotropic potential of SARS-CoV-2 in pediatric populations.
Observation:
- A case report of a child experiencing convulsive status epilepticus is presented.
- The child had a confirmed diagnosis of COVID-19 infection.
Findings:
- The study documents a direct correlation between SARS-CoV-2 infection and neurological complications in a pediatric patient.
- Convulsive status epilepticus was the presenting neurological manifestation.
Implications:
- This case underscores the importance of considering COVID-19 in children presenting with new-onset seizures.
- Further research is needed to fully understand the neurological impact of SARS-CoV-2 in children.
More Related Videos
09:57Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
Published on: September 20, 2024
2.9K
08:28Methods for ECG Evaluation of Indicators of Cardiac Risk, and Susceptibility to Aconitine-induced Arrhythmias in Rats Following Status Epilepticus
Published on: April 5, 2011
17.9K
Related Concept Videos
01:24Epilepsy and Seizures: Overview
385
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
385
01:13Seizures: Classification
706
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
706
01:30Electroconvulsive Therapy
285
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
285
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
822
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
822
01:14Antiepileptic Drugs: Glutamate Antagonists
604
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
604
01:20Antiepileptic Drugs: Potassium Channel Activators
372
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
372